Trisenox Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Trisenox Side Effects
Did You Have Trisenox Side Effect? |
Trisenox Side Effects Poll Results |
|
Vote Below:
|
|
Trisenox Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Trisenox:
What is Your Question? Ask Community:
Daily Health Videos
Trisenox Side Effects reported on Patientsville.com
None reported at this time.Trisenox Side Effects reported to FDA
Showing 1-50 of 401 Next >
Trisenox Side Effects Report #5201251-9Physician from JAPAN reported Trisenox side effect on Dec 20, 2006. Male patient, 70 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, ventricular extrasystoles, ventricular tachycardia. Trisenox dosage: 77.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, HYDROXYCARBAMIDE, NAFAMOSTAT MESILATE, CEFMETAZOLE, SPIRONOLACTONE. Patient recovered.
Trisenox Side Effects Report #5201330-6
Trisenox side effect was reported by a Physician from JAPAN on Dec 19, 2006. Female patient, 20 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chest discomfort, torsade de pointes, ventricular extrasystoles. Trisenox dosage: 0.15 MG/KG QD INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE. Patient recovered.
Trisenox Side Effects Report #5208618-3
Consumer or non-health professional from UNITED STATES reported Trisenox side effect on Jan 02, 2007. Female patient, 56 years of age, weighting 259.0 lb, was diagnosed with depression
, hypertension, anxiety , prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alveolar osteitis, asthenia, bone disorder, bronchitis , constipation , dental treatment, diarrhoea, dysgeusia, dyspepsia. Trisenox dosage: unknown. During the same period patient was treated with PAMELOR, VERAPAMIL, DEXAMETHASONE, ZOLOFT, ATIVAN, TRAZODONE, FILGRASTIM, ACLOVIR. Patient recovered.Trisenox Side Effects Report #5220983-X
Trisenox side effect was reported by a Physician from JAPAN on Jan 09, 2007. Female patient, 62 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, leukocytosis. Trisenox dosage: 8.19 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN HDYROCHLORIDE, CYTARABINE, DANAPAROID. Patient recovered.
Trisenox Side Effects Report #5223699-9
Physician from JAPAN reported Trisenox side effect on Jan 12, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles. Trisenox dosage: unknown. Patient recovered.
Trisenox Side Effects Report #5233337-7
Trisenox side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 76 years of age, weighting 187.0 lb, was diagnosed with myelodysplastic syndrome, iron overload and was treated with Trisenox. After drug was administered, patient experienced the following side effects: ascites, cardiac failure congestive, electrocardiogram qt prolonged, fluid overload, mitral valve incompetence, pleural effusion, pneumonia
, splenomegaly, tricuspid valve incompetence. Trisenox dosage: 0.25 MG/KG TWICE WEEKLY Q72HR INTRAVENOUS DRIP. During the same period patient was treated with EXJADE, THALIDOMIDE, ACYCLOVIR, ASCORBIC ACID. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5233587-X
Physician from JAPAN reported Trisenox side effect on Jan 23, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5234218-5
Trisenox side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2007. Male patient, 73 years of age, weighting 202.8 lb, was diagnosed with chronic myelomonocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: haematuria, nephrolithiasis, renal failure. Trisenox dosage: 0.25 MG/KG QD DAYS 1-5, DAYS 8-12 INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, HYDREA. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5235169-2
Physician from JAPAN reported Trisenox side effect on Jan 24, 2007. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disseminated intravascular coagulation, respiratory distress, sepsis
. Trisenox dosage: 5 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, SPIRONOLACTONE, NICORANDIL, AMLODIPINE BESYLATE, FAMOTIDINE, ALLOPURINOL. Patient died on 11/10/2006.Trisenox Side Effects Report #5245997-5
Trisenox side effect was reported by a Physician from JAPAN on Feb 02, 2007. Female patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, condition aggravated, disseminated intravascular coagulation, respiratory distress, sepsis
. Trisenox dosage: 5 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, SPIRONOLACTONE, NICORANDIL, AMLODIPNE BESILATE, FAMOTIDINE, ALLOPURINOL. Patient recovered.Trisenox Side Effects Report #5247249-6
Physician from UNITED STATES reported Trisenox side effect on Feb 12, 2007. Female patient, 56 years of age, weighting 259.0 lb, was diagnosed with depression
, hypertension, anxiety , prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alveolar osteitis, asthenia, bone disorder, bronchitis , constipation , dental treatment, diarrhoea, dysgeusia, dyspepsia. Trisenox dosage: unknown. During the same period patient was treated with PAMELOR, VERAPAMIL, DEXAMETHASONE, ZOLOFT, ATIVAN, TRAZODONE, FILGRASTIM, ACLOVIR. Patient recovered.Trisenox Side Effects Report #5248064-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 07, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5248065-1
Physician from JAPAN reported Trisenox side effect on Feb 06, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, catheter related infection, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, pathogen resistance, staphylococcal infection
. Trisenox dosage: 9.69 MG Q1D INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, METHYLPHENIDATE, ALPRAZOLAM, MILNACIPRAN HYDROCHLORIDE, AMIKACIN SULPHATE, PAROXETINE HYDROCHLORIDE. Patient recovered.Trisenox Side Effects Report #5252018-7
Trisenox side effect was reported by a Physician from UNITED STATES on Feb 09, 2007. Male patient, 73 years of age, weighting 202.8 lb, was diagnosed with chronic myelomonocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: nephrolithiasis, platelet count decreased, renal failure. Trisenox dosage: 0.25 MG/KG QD DAYS 1-5, DAYS 8-12 INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, HYDREA. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5228030-0
Pharmacist from UNITED STATES reported Trisenox side effect on May 05, 2006. Female patient, 14 years of age, weighting 61.73 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: pyrexia. Trisenox dosage: 10 MG DAYS 1-5 X 5 WEEKS QD INTRAVENOUS DRIP. During the same period patient was treated with ZOFRAN. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5257757-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 15, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, protein total decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5260932-1
Physician from JAPAN reported Trisenox side effect on Feb 20, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, blood urea decreased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, protein total decreased, rash
, white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5266132-3
Trisenox side effect was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation. Trisenox dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN, DANAPAROID, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, MONOAMMONIUM GLYCYRRHIZINATE. Patient died on 12/31/2006.
Trisenox Side Effects Report #5270157-1
Physician from JAPAN reported Trisenox side effect on Feb 28, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, hepatic function abnormal, herpes zoster, liver disorder, rash
. Trisenox dosage: 8.0625MG. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.Trisenox Side Effects Report #5278708-8
Trisenox side effect was reported by a Physician from JAPAN on Mar 05, 2007. Male patient, 53 years of age, was treated with Trisenox. After drug was administered, patient experienced the following side effects: pancytopenia, respiratory failure. Trisenox dosage: unknown. Patient recovered.
Trisenox Side Effects Report #5281885-6
Physician from JAPAN reported Trisenox side effect on Mar 12, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hypokalaemia, pancytopenia. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CEFDINIR, ETIZOLAM, FEXOFENADINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, GEFARNATE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5292474-1
Trisenox side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, blood alkaline phosphatase increased, blood potassium decreased, blood urea increased, electrocardiogram qt prolonged, malaise, malignant neoplasm progression, renal impairment, sepsis
. Trisenox dosage: 9.165 MG QD INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN N, CEFTAZIDIME, MICAFUNGIN, IDARUBICIN, CYTARABINE, DALTEPARIN, ISEPAMICIN SULPHATE. Patient was hospitalized. Patient died on 04/18/2006.Trisenox Side Effects Report #5301086-2
Physician from JAPAN reported Trisenox side effect on Mar 26, 2007. Female patient, 37 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: accelerated idioventricular rhythm, alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt corrected interval prolonged, gamma-glutamyltransferase increased, leukocytosis, nausea
. Trisenox dosage: 8.978 MG QD INTRAVENOUS DRIP. During the same period patient was treated with MEXILETINE HYDROCHLORIDE, GRANISETRN HYDROCHLORIDE. Patient recovered.Trisenox Side Effects Report #5301184-3
Trisenox side effect was reported by a Physician from JAPAN on Mar 26, 2007. Female patient, 59 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, pancytopenia. Trisenox dosage: 7.065 MG QD INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE, PREDNISOLONE ACETATE. Patient recovered.
Trisenox Side Effects Report #5306139-0
Physician from JAPAN reported Trisenox side effect on Apr 02, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE. Patient died on 01/19/2006.
Trisenox Side Effects Report #5309186-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 09, 2007. Female patient, 77 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood lactate dehydrogenase increased, electrocardiogram qt prolonged, fibrin d dimer increased, gamma-glutamyltransferase increased, protein total decreased, white blood cell count decreased. Trisenox dosage: 9.315 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5320867-2
Physician from JAPAN reported Trisenox side effect on Apr 24, 2007. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BROTIZOLAM, ETIZOLAM. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5320868-4
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, ascites, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, neuropathy peripheral, pancytopenia, pleural effusion, respiratory failure, weight increased. Trisenox dosage: 8.25 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, FUROSEMIDE, DANAPAROID. Patient recovered.
Trisenox Side Effects Report #5320869-6
Physician from JAPAN reported Trisenox side effect on Apr 23, 2007. Male patient, 50 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, csf test abnormal, cytology abnormal, gamma-glutamyltransferase increased, hepatic function abnormal. Trisenox dosage: 9.48 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FLUCONAZOLE, FAMOTIDINE. Patient recovered.
Trisenox Side Effects Report #5320873-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 23, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia, arrhythmia
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, febrile neutropenia, herpes zoster, liver disorder, rash . Trisenox dosage: 8.0625 MG DAILY. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.Trisenox Side Effects Report #5320874-X
Physician from JAPAN reported Trisenox side effect on Apr 25, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: sensory disturbance. Trisenox dosage: 7.5 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5320875-1
Trisenox side effect was reported by a Physician from JAPAN on Apr 25, 2007. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: arrhythmia
. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5320876-3
Physician from JAPAN reported Trisenox side effect on Apr 24, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, cerebral haemorrhage, cheilitis, chills, condition aggravated, disseminated intravascular coagulation, hyperhidrosis, pyrexia, rash
. Trisenox dosage: 9.075 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, CANDESARTAN CILEXETIL, MEROPENEM TRIHYDRATE, LENOGRASTIM. Patient was hospitalized. Patient died on 03/22/2007.Trisenox Side Effects Report #5325380-4
Trisenox side effect was reported by a Physician from JAPAN on Apr 26, 2007. Female patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood bilirubin increased, cerebral haemorrhage, condition aggravated, dialysis
, disseminated intravascular coagulation, hyperglycaemia, leukocytosis, pulmonary haemorrhage. Trisenox dosage: 7.62 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ETOPOSIDE, TEICOPLANIN, NAFAMOSTAT MESILATE, MICONAZOLE, HYDROCORTISONE SUCCINATE, FAMOTIDINE. Patient died on 11/09/2005.Trisenox Side Effects Report #5325386-5
Physician from JAPAN reported Trisenox side effect on Apr 24, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis, renal failure. Trisenox dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.
Trisenox Side Effects Report #5331422-2
Trisenox side effect was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, 61 years of age, weighting 185.0 lb, was diagnosed with multiple myeloma
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: pulmonary embolism . Trisenox dosage: 21 MG DAILY FOR 7 DAYS INTRAVENOUS DRIP. During the same period patient was treated with VELCADE, ASCORBIC ACID, MELPHALAN, SERTRALINE, METOPROLOL SUCCINATE EXTENDED RELEASE, HYDROCHLOROTHIAZIDE, OXYCODONE, LORAZEPAM. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5336511-4
Physician from JAPAN reported Trisenox side effect on May 14, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash
, white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5354590-5
Trisenox side effect was reported by a Physician from JAPAN on June 04, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, brain stem infarction, dysphagia, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, haemodialysis. Trisenox dosage: 10.05 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, CALCIUM GLUCONATE. Patient recovered.
Trisenox Side Effects Report #5361222-9
Physician from JAPAN reported Trisenox side effect on June 04, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood pressure systolic decreased, bone marrow failure, c-reactive protein increased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pleural effusion, respiratory arrest, urine output decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, PREDNISOLONE SUCCINATE, NAFAMOSTAT, LENOGRASTIM. Patient died on 05/06/2007.
Trisenox Side Effects Report #5368842-6
Trisenox side effect was reported by a Physician from JAPAN on June 13, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hepatic function abnormal, hypocalcaemia, leukopenia. Trisenox dosage: 9.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FEXOFENADINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, GEFARNATE, ETIZOLAM, ZOLPIDEM TARTRATE. Patient recovered.
Trisenox Side Effects Report #5371533-9
Physician from UNITED STATES reported Trisenox side effect on June 15, 2007. Female patient, 55 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma
, neoplasm recurrence and was treated with Trisenox. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiotoxicity, disease progression, ejection fraction decreased, fall , fatigue, pain , pericardial effusion, pleural effusion. Trisenox dosage: 0.25 MG/KG DAYS 1-5 INTRAVENOUS DRIP. During the same period patient was treated with ASCORBIC ACID, BORTEZOMIB, ZYDONE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5373417-9
Trisenox side effect was reported by a Pharmacist from UNITED STATES on June 26, 2007. Female patient, weighting 194.0 lb, was diagnosed with ill-defined disorder and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chills, dyspnoea, infusion related reaction, pyrexia. Trisenox dosage: 12.45 MG 5X/WEEK FOR 5 WKS IV. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5047197-0
Physician from JAPAN reported Trisenox side effect on June 21, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disseminated intravascular coagulation, haemoglobin decreased, hypokalaemia, malignant neoplasm progression, platelet count decreased, renal failure, respiratory failure. Trisenox dosage: 4.1 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, NIZATIDINE, INSULIN. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5047198-2
Trisenox side effect was reported by a Physician from JAPAN on June 23, 2006. Male patient, 64 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased. Trisenox dosage: 8.76 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, IDARUBICIN, MEXILETINE HYDROCHLORIDE, GABEXATE MESILATE, AMIKACIN SULPHATE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5047199-4
Physician from JAPAN reported Trisenox side effect on June 23, 2006. Male patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hyperglycaemia, pyrexia. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, DALTEPARIN, MICAFUNGIN, ACYCLOVIR, AMIKACIN SULPHATE, TAZOBACTAM PIPERACILLIN, CEFTAZIDIME. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5061934-0
Trisenox side effect was reported by a Physician from UNITED STATES on July 07, 2006. Male patient, 68 years of age, weighting 150.0 lb, was diagnosed with myeloid leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: convulsion, subdural haematoma. Trisenox dosage: 17 MG 0.25MG/KG; DAYS 1-5; DAYS 8-12 QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5062550-7
Physician from JAPAN reported Trisenox side effect on July 07, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5062859-7
Trisenox side effect was reported by a Physician from JAPAN on July 12, 2006. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, malignant neoplasm progression, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 9.353 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, CANDESARTAN CILEXETIL. Patient recovered.
Trisenox Side Effects Report #5062934-7
Physician from JAPAN reported Trisenox side effect on July 07, 2006. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: 9 MG ROUTE: INTRAVENOUS DRIP QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5070308-8
Trisenox side effect was reported by a Physician from JAPAN on July 18, 2006. Male patient, 54 years of age, was treated with Trisenox. After drug was administered, patient experienced the following side effects: white blood cell count decreased. Trisenox dosage: unknown. Patient recovered.
Showing 1-50 of 401 Next >